| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
3,280,000 |
| Market
Cap: |
1.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3437 - $4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. Co.'s primary investigational product is the LOMECEL-B™ cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. Co. is sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome, and hypoplastic left heart syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
297,872 |
322,872 |
322,872 |
322,872 |
| Total Buy Value |
$699,999 |
$734,301 |
$734,301 |
$734,301 |
| Total People Bought |
3 |
6 |
6 |
6 |
| Total Buy Transactions |
5 |
9 |
9 |
9 |
| Total Shares Sold |
0 |
0 |
23,532 |
219,987 |
| Total Sell Value |
$0 |
$0 |
$81,541 |
$1,060,824 |
| Total People Sold |
0 |
0 |
1 |
3 |
| Total Sell Transactions |
0 |
0 |
3 |
10 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lehr Paul T |
General Counsel, Secretary |
• – – |
2022-07-01 |
4 |
D |
$5.94 |
$9,676 |
D/D |
(1,629) |
149,949 |
|
- |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2022-07-01 |
4 |
D |
$5.94 |
$8,470 |
D/D |
(1,426) |
78,193 |
|
- |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2022-06-03 |
4 |
S |
$8.26 |
$305,248 |
D/D |
(36,955) |
79,619 |
|
59% |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2022-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
116,574 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2022-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
151,578 |
|
- |
|
| Soffer Rock |
|
– • – |
2022-05-24 |
4 |
S |
$7.50 |
$30,000 |
D/D |
(4,000) |
672,351 |
|
48% |
|
| Soffer Rock |
|
– • – |
2022-05-23 |
4 |
S |
$7.78 |
$62,200 |
D/D |
(8,000) |
676,351 |
|
52% |
|
| Soffer Rock |
|
– • – |
2022-05-20 |
4 |
S |
$8.06 |
$60,435 |
D/D |
(7,500) |
684,351 |
|
55% |
|
| Soffer Rock |
|
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
500,182 |
691,851 |
|
- |
|
| Soffer Donald M |
|
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,535,223 |
6,693,737 |
|
- |
|
| Soffer Donald M |
|
– • – |
2022-05-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,024,208) |
0 |
|
- |
|
| Ds Med Llc |
|
– – • |
2022-05-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,024,208) |
0 |
|
- |
|
| Hare Joshua |
Chief Scientific Officer |
• • • |
2022-04-19 |
4 |
AS |
$10.00 |
$780 |
D/D |
(78) |
7,913,263 |
|
-48% |
|
| Hare Joshua |
Chief Scientific Officer |
• • • |
2022-04-18 |
4 |
AS |
$10.00 |
$199,290 |
D/D |
(19,922) |
7,913,341 |
|
-44% |
|
| Soffer Donald M |
|
– • – |
2022-04-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(748,694) |
7,024,208 |
|
- |
|
| Min Kwan-Hong Christopher |
Chief Medical Officer |
• – – |
2022-04-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
152,335 |
151,978 |
|
- |
|
| Min Kwan-Hong Christopher |
Chief Medical Officer |
• – – |
2022-04-04 |
4/A |
D |
$0.00 |
$0 |
D/D |
(357) |
1,978 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2022-04-04 |
4 |
D |
$15.61 |
$22,978 |
D/D |
(1,472) |
111,578 |
|
- |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2022-04-04 |
4 |
D |
$15.61 |
$20,106 |
D/D |
(1,288) |
76,574 |
|
- |
|
| Green Geoff |
CEO |
• – – |
2022-04-04 |
4 |
D |
$15.61 |
$28,722 |
D/D |
(1,840) |
133,904 |
|
- |
|
| Min Kwan-Hong Christopher |
Chief Medical Officer |
• – – |
2022-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
152,335 |
152,335 |
|
- |
|
| Girolamo Todd C |
|
– • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2022-01-05 |
4 |
D |
$12.09 |
$40,090 |
D/D |
(3,316) |
113,050 |
|
- |
|
| Green Geoff |
CEO |
• – – |
2022-01-03 |
4 |
D |
$12.09 |
$48,106 |
D/D |
(3,979) |
135,744 |
|
- |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2022-01-03 |
4 |
D |
$12.09 |
$20,988 |
D/D |
(1,736) |
77,862 |
|
- |
|
115 Records found
|
|
Page 3 of 5 |
|
|
